BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Atherosclerosis is a systemic disease with different faces. Despite identical or similar
pathogenetic mechanisms, atherosclerotic lesions and their clinical manifestations vary in …

Aim At present, the relationship between serum homocysteine (Hcy), fibrinogen (FIB),
lipoprotein-a (LPa), and PAD is uncertain, and there has been no meta-analysis to establish …

Lipoprotein (a) is an apolipoprotein B100-containing low-density lipoprotein-like particle that
is rich in cholesterol, and is associated with a second major protein, apolipoprotein (a) …

Background Inflammatory bowel disease (IBD) has been associated with lipid-lowering
drugs in observational studies. Drug-target Mendelian randomization (MR) was utilized in …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and
mortality among Western populations. Many risk factors have been identified for ASCVD; …

To study the relationship of serum PCSK9 and disease activity and major adverse
cardiovascular events (MACEs) in systemic lupus erythematosus (SLE). Consecutive …

Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key
regulator of lipid homeostasis. A few earlier genome-wide association studies (GWAS) …

The current step up approach in the therapy of dyslipidemias aims to reduce the amount of
LDL cholesterol below a threshold that varies according to the patient's risk category, with a …

Despite a clear epidemiological link between autoimmune disease and cardiovascular (CV)
risk exists, pathophysiological explanations are extremely complex and far from being …